Celltrion Pharm Inc
KOSDAQ:068760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
KR |
|
Capgemini SE
OTC:CGEMY
|
FR |
|
T
|
TTM Technologies Inc
DUS:TT1
|
US |
Intrinsic Value
The intrinsic value of Celltrion Pharm Inc (068760) under the Base Case is 46 376.46 KRW per share. Compared with the current market price of 37 050 KRW, the stock appears Undervalued by 20% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Celltrion Pharm Does
Celltrion Pharm Inc. makes prescription medicines and sells them mainly in South Korea. Its product line includes generic drugs and hospital-focused treatments such as injectables and other branded medicines used for conditions like ulcers, allergies, infections, and chronic diseases. The company earns money by manufacturing these drugs and selling them through pharmacies, hospitals, and drug distributors.
- Headquarters
- Korea KR
- Employees
- 243
- IPO date
- Feb 3, 2006
Revenue & Expenses Breakdown
Celltrion Pharm Inc
Earnings Waterfall
Celltrion Pharm Inc
The intrinsic value for Celltrion Pharm Inc (068760) under the Base Case is 46 376.46 KRW.
Compared with the current market price of 37 050 KRW, the stock appears Undervalued by 20% .